Bausch + Lomb Corporation (BLCO)

13,86 +0,12 (+0,87 %) À la clôture : 04:00PM EDT

Bausch + Lomb Corporation

520 Applewood Crescent
Vaughan, ON L4K 4B4
Canada
(905) 695-7700
https://www.bausch.com

Secteur(s): Healthcare
Secteur d’activité: Medical Instruments & Supplies
Employés à temps plein: 13 300

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Osama A. Eldessouky	Executive VP & CFO	1,09M	S.O.	1972
Mr. Brenton L. Saunders J.D.	CEO & Chairman	S.O.	S.O.	1970
Mr. Alan Waterhouse CPFA, MBA	Executive VP and Chief Supply Chain & Operations Officer	S.O.	S.O.	1960
Mr. Frederick J. Munsch	Senior VP, Controller & Chief Accounting Officer	S.O.	S.O.	1971
Mr. A. Robert D. Bailey	Executive VP & Chief Legal Officer	S.O.	S.O.	1963
Mr. Jonathon L. Kellerman	Chief Compliance Officer	S.O.	S.O.	S.O.
T.J. Crawford	Chief Communications Officer	S.O.	S.O.	S.O.
Dr. Manisha A. Narasimhan Ph.D.	Chief Corporate Development & Digital Officer	S.O.	S.O.	1977
Ms. Asli Gevgilili	Executive VP & Chief Human Resources Officer	S.O.	S.O.	S.O.
Mr. John Ferris	Executive Vice President of Consumer	S.O.	S.O.	S.O.

Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Bausch + Lomb Corporation en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.